Carib A. Oquendo

Array ( [id] => 7811451 [patent_doc_number] => 08133982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'FcγRIIB specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/349876 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 67259 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133982.pdf [firstpage_image] =>[orig_patent_app_number] => 12349876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533022 [patent_doc_number] => 20090232810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/342407 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25064 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232810.pdf [firstpage_image] =>[orig_patent_app_number] => 12342407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928910 [patent_doc_number] => 20110038869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST CD32B' [patent_app_type] => utility [patent_app_number] => 12/811637 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 39436 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038869.pdf [firstpage_image] =>[orig_patent_app_number] => 12811637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676329 [patent_doc_number] => 08815237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Aglycosylated immunoglobulin mutants' [patent_app_type] => utility [patent_app_number] => 12/746411 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 24223 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270657 [patent_doc_number] => 20100254976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'USE OF PROTEASE NEXIN 1 INHIBITORS TO REDUCE METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/746214 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18769 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254976.pdf [firstpage_image] =>[orig_patent_app_number] => 12746214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11429082 [patent_doc_number] => 09567390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Humanized high affinity recombinant antibody against Hepatitis B surface antigen' [patent_app_type] => utility [patent_app_number] => 12/865623 [patent_app_country] => US [patent_app_date] => 2008-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 5572 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110342 [patent_doc_number] => 20110189203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'IMMUNOGLOBULIN CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 12/745023 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14640 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189203.pdf [firstpage_image] =>[orig_patent_app_number] => 12745023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386346 [patent_doc_number] => 08263743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Humanized antibodies against TL1A' [patent_app_type] => utility [patent_app_number] => 12/270673 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7981 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12270673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081537 [patent_doc_number] => 08148087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Detection of dysplastic or neoplastic cells using anti-MCM6 antibodies' [patent_app_type] => utility [patent_app_number] => 12/264456 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15884 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148087.pdf [firstpage_image] =>[orig_patent_app_number] => 12264456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373695 [patent_doc_number] => 20090311256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => '12 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 12/264040 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 290627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12264040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5507965 [patent_doc_number] => 20090081172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/258545 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17090 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081172.pdf [firstpage_image] =>[orig_patent_app_number] => 12258545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585943 [patent_doc_number] => 20090105145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Method of Diagnosing and Treating Colon Cancer' [patent_app_type] => utility [patent_app_number] => 12/255360 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14810 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105145.pdf [firstpage_image] =>[orig_patent_app_number] => 12255360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404722 [patent_doc_number] => 20090240037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HUMANIZED ANTIBODIES AND METHODS OF HUMANIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/250396 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 36937 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20090240037.pdf [firstpage_image] =>[orig_patent_app_number] => 12250396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309754 [patent_doc_number] => 20090017035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4' [patent_app_type] => utility [patent_app_number] => 12/245392 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15937 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017035.pdf [firstpage_image] =>[orig_patent_app_number] => 12245392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560710 [patent_doc_number] => 09284369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Inhibition of angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/679257 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 107 [patent_no_of_words] => 52254 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7539949 [patent_doc_number] => 08057791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Human antibodies specific to KDR and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/234203 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 13998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/057/08057791.pdf [firstpage_image] =>[orig_patent_app_number] => 12234203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9711036 [patent_doc_number] => 08835606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Anti-cancer antibodies with reduced complement fixation' [patent_app_type] => utility [patent_app_number] => 12/209935 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 5514 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12209935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195512 [patent_doc_number] => 20110027266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Humanized anti-CXCR5 antibodies, derivatives thereof and their use' [patent_app_type] => utility [patent_app_number] => 12/675799 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43911 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027266.pdf [firstpage_image] =>[orig_patent_app_number] => 12675799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4857 [patent_doc_number] => 07812128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Gene overexpressed in cancer' [patent_app_type] => utility [patent_app_number] => 12/229750 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 88 [patent_no_of_words] => 55157 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812128.pdf [firstpage_image] =>[orig_patent_app_number] => 12229750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949387 [patent_doc_number] => 20080305513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'METHOD OF MEASURING CANCER AGGRESSIVENESS AND DETECTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/194163 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10221 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305513.pdf [firstpage_image] =>[orig_patent_app_number] => 12194163 [rel_patent_id] =>[rel_patent_doc_number] =>)